1-843-792-WEED wagne@musc.edu

MUSC

The purpose of this study is to determine if a medication called varenicline (Chantix) is an effective treatment for cannabis use and in helping people cut back or quit using marijuana. Study participants will receive study medication and care at no cost. They will also be paid weekly for their participation. This study will involve approximately 72 participants. Drs. Aimee McRae-Clark and Kevin Gray are the investigators in charge of this study.

What type of study is this?

This is a clinical trial for people seeking to reduce or stop their marijuana use.

How long is the study?

Participants can expect to commit to the study for approximately eight (8) weeks.

What will be expected of me if I participate in the study?

Participants can expect study activities to include:

Screening interview and physical

Filling out forms

Undergoing two (2) MRI scans

Providing urine and breath samples

Bi-weekly study visits for six (6) weeks

Three (3) individual therapy sessions

Taking a medication or placebo daily for six (6) weeks

Will I be paid for this study?

Yes. Participants will be paid for study-related time and travel.

Who is eligible for the study?

Men and women, ages 18 – 65, who currently use marijuana on a regular basis.

Where is the study located?

This study is being conducted at the Medical University of South Carolina, located in Charleston, SC.

We are located in the Roper Medical Office Building.

Our address is:

125 Doughty Street, Suite 190
Charleston, SC  29403

If you would like more information about the study, or would like to see if you qualify, please contact Amanda at (843) 792-WEED or wagne@musc.edu. All calls are confidential.